Cervical stromal invasion and molecular characterization in stage II-IV endometrial cancers.

Objective: The optimal treatment for patients with cervical stromal invasion (CSI) in endometrial cancer (EC) remains unclear. We aimed to test the prognostic role of molecular classification in EC patients with CSI.

Methods: A retrospective, multicenter review of EC patients with CSI was performed.